back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-06-09 14:37 Tx date 2023-06-09 |
$NEON
Lancaster Resources Inc. |
Tessarolo, Robert Dean
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+104,000 vol |
104,000 | |
| Filed 2023-06-09 14:36 Tx date 2021-01-27 |
$NEON
Lancaster Resources Inc. |
Tessarolo, Robert Dean
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-06-09 14:36 Tx date 2023-06-09 |
$NEON
Lancaster Resources Inc. |
Tessarolo, Robert Dean
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+180,000 vol |
180,000 | |
| Filed 2023-06-09 14:35 Tx date 2023-06-09 |
$NEON
Lancaster Resources Inc. |
Tessarolo, Robert Dean
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+133,000 vol |
133,250 | |
| Filed 2023-01-30 01:43 Tx date 2023-01-24 |
$NEON
NeonMind Biosciences Inc. |
Tessarolo, Robert Dean
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-7,250 vol |
250 | |
| Filed 2023-01-03 13:26 Tx date 2022-12-29 |
$NEON
NeonMind Biosciences Inc. |
Tessarolo, Robert Dean
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-850,000 vol |
0 | |
| Filed 2022-12-30 17:38 Tx date 2022-12-28 |
$NEON
NeonMind Biosciences Inc. |
Tessarolo, Robert Dean
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,500,000 vol |
7,500 | |
| Filed 2022-12-29 16:20 Tx date 2022-12-28 |
$NEON
NeonMind Biosciences Inc. |
Tessarolo, Robert Dean
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-1,100,000 vol |
850,000 | |
| Filed 2022-08-09 09:26 Tx date 2022-08-08 |
$NEON
NeonMind Biosciences Inc. |
Tessarolo, Robert Dean
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+850,000 vol |
1,950,000 | |
| Filed 2022-06-09 14:12 Tx date 2022-06-08 |
$NEON
NeonMind Biosciences Inc. |
Tessarolo, Robert Dean
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-150,000 vol |
1,100,000 | |
| Filed 2022-06-09 14:11 Tx date 2022-06-08 |
$NEON
NeonMind Biosciences Inc. |
Tessarolo, Robert Dean
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-1,000,000 vol |
1,250,000 | |
| Filed 2022-06-09 13:59 Tx date 2022-06-07 |
$NEON
NeonMind Biosciences Inc. |
Tessarolo, Robert Dean
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+2,500,000 vol |
2,507,500 | |
| Filed 2022-06-09 13:58 Tx date 2022-06-07 |
$NEON
NeonMind Biosciences Inc. |
Tessarolo, Robert Dean
4 - Director of Issuer
Direct Ownership
|
Restricted Share Unit
36 - Conversion or exchange
|
-2,500,000 vol |
0 | |
| Filed 2022-06-07 14:02 Tx date 2022-06-07 |
$NEON
NeonMind Biosciences Inc. |
Tessarolo, Robert Dean
4 - Director of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
+2,500,000 vol |
2,500,000 | |
| Filed 2022-06-07 13:57 Tx date 2022-06-07 |
$NEON
NeonMind Biosciences Inc. |
Tessarolo, Robert Dean
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,100,000 vol |
2,250,000 | |
| Filed 2022-04-22 13:16 Tx date 2022-04-18 |
$NEON
NeonMind Biosciences Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-3,450,000 vol |
1,150,000 | |
| Filed 2022-04-22 13:09 Tx date 2022-04-18 |
$NEON
NeonMind Biosciences Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-22,500 vol |
7,500 | |
| Filed 2021-07-28 16:33 Tx date 2021-07-26 |
$NEON
NeonMind Biosciences Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
38 - Redemption, retraction, cancellation, repurchase
|
-270,000 vol |
0 | |
| Filed 2021-07-21 17:08 Tx date 2021-07-20 |
$NEON
NeonMind Biosciences Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+600,000 vol |
4,600,000 | |
| Filed 2021-07-21 17:06 Tx date 2021-07-20 |
$NEON
NeonMind Biosciences Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
-600,000 vol |
||
| Filed 2021-05-28 19:56 Tx date 2021-05-27 |
$NEON
NeonMind Biosciences Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+30,000 vol |
30,000 | |
| Filed 2021-05-28 19:54 Tx date 2021-05-27 |
$NEON
NeonMind Biosciences Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$900,000,000
+30,000 vol $30,000 each |
||
| Filed 2021-05-28 19:53 Tx date 2021-01-27 |
$NEON
NeonMind Biosciences Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-28 19:53 Tx date 2021-05-27 |
$NEON
NeonMind Biosciences Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
36 - Conversion or exchange
|
-30,000 vol |
270,000 | |
| Filed 2021-01-28 12:37 Tx date 2021-01-27 |
$NEON
NeonMind Biosciences Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+4,000,000 vol |
4,000,000 | |
| Filed 2021-01-28 12:36 Tx date 2021-01-27 |
$NEON
NeonMind Biosciences Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-01-28 12:35 Tx date 2021-01-27 |
$NEON
NeonMind Biosciences Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
+300,000 vol |
300,000 | |
| Filed 2021-01-28 12:33 Tx date 2021-01-27 |
$NEON
NeonMind Biosciences Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-04-23 22:25 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+55,973 vol |
96,697 | |
| Filed 2019-04-23 18:44 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
+55,973 vol |
96,697 | |
| Filed 2019-04-23 18:44 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
+55,973 vol |
||
| Filed 2019-04-23 18:42 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$290,327
+196,167 vol $1.48 each |
484,181 | |
| Filed 2019-04-23 17:57 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$290,327
+196,167 vol $1.48 each |
484,181 | |
| Filed 2019-04-23 17:57 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$290,327
+196,167 vol $1.48 each |
||
| Filed 2019-04-17 13:06 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+7,593 vol |
44,606 | |
| Filed 2019-04-17 13:04 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-14,947 vol |
40,724 | |
| Filed 2018-04-06 Tx date 2018-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-4,113 vol |
55,671 | |
| Filed 2018-04-06 Tx date 2018-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
||
| Filed 2018-04-06 Tx date 2018-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
||
| Filed 2018-04-06 Tx date 2018-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+4,113 vol |
37,013 | |
| Filed 2018-03-26 Tx date 2018-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$698,989
+198,014 vol $3.53 each |
288,014 | |
| Filed 2018-03-26 Tx date 2018-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+43,334 vol |
59,784 | |
| Filed 2017-09-25 Tx date 2017-09-20 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+29,151 vol |
29,151 | |
| Filed 2017-09-25 Tx date 2017-04-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-05-26 Tx date 2017-05-23 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+16,450 vol |
16,450 | |
| Filed 2017-05-26 Tx date 2017-04-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-05-19 Tx date 2017-04-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-05-19 Tx date 2017-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$455,399
+90,000 vol $5.06 each |
90,000 | |
| Filed 2017-05-10 Tx date 2017-04-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
32,900 |